The safety and effectiveness of Multimin^® 90 (zinc, copper, manganese, and selenium injection) as a supplemental source of key trace minerals was confirmed by the Center for Veterinary Medicine and the U.S. Food and Drug Administration when the product was approved as a new animal drug in April 2024. The transition to the FDA-approved product and labeling is now complete. The approval is the culmination of a significant multi-year investment in research for this novel innovation and ensures that Multimin 90 is safe, effective and manufactured to the highest standards. Axiota is one of the few companies to partner with FDA to move a currently marketed product through the drug approval process.

Trace minerals are essential for key functions in the body. While a dietary mineral program is key for cattle health, even the best oral programs face challenges. Variation in intake, antagonists, poor digestibility and changes in demand can result in uneven trace mineral status in the herd. The most effective trace mineral programs address these challenges by incorporating strategic supplementation that ensures even treatment across the herd. Cattle that are fully supplemented are more prepared for periods of transition and stress.

Multimin 90 is the only FDA-approved drug that contains four trace minerals known to support cattle health. Its subcutaneous injectable format for supplementation results in a significant rise in levels of zinc, copper, manganese and selenium in the blood within 8–10 hours of injection and liver storage within 24 hours.¹ Multimin 90 complements oral trace mineral programs and is a safe and effective option to strategically supplement four key trace minerals.

William (Bill) Weldon, Axiota Chief Executive Officer, said “The approval of Multimin 90 as a new animal drug confirms that the product veterinarians and beef and dairy producers have relied on since 2010 meets the highest standards of quality, safety, and efficacy for animal health products. Taking the additional steps to secure FDA approval is a testament to Axiota’s continued commitment to provide a reliable and high-quality supply of trusted, proven products to cattle producers.”

The United States joins more than 30 other countries where Multimin 90 is approved, including several countries in key cattle-producing areas of Europe, North America and Latin America. For more information about Multimin 90, visit axiota.com or contact your Axiota sales representative.

About Axiota Animal Health
Axiota delivers best-in-class animal health products with proven modes of action. Axiota’s focus is to help producers manage risk and support cattle health, performance and well-being across multiple stages of beef and dairy production.

IMPORTANT SAFETY INFORMATION FOR MULTIMIN^® 90: Not for use in humans, keep out of reach of children. Multimin 90 has a preslaughter withdrawal time of 14 days after injection. Do not use during the first trimester of pregnancy or in pre-ruminant calves as safety has not been established. Selenium and copper are toxic if administered in excess and may lead to sudden death, depression, weakness, ataxia, salivation, and drooling. Do not use concurrently with other selenium or copper injections or boluses. Maximum volume per injection site is 7 mL. Allow a minimum of 30 days before considering repeat dosing. See prescribing information at axiota.com/label.

NADA 141-582

¹Pogge, D.J., et al. 2012. J. Anim. Sci. 90(8): 2692–2698.

AX-00075-00
© 2025 Axiota®